FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism - Concepedia

Concepedia

Publication | Open Access

FKBPL and Peptide Derivatives: Novel Biological Agents That Inhibit Angiogenesis by a CD44-Dependent Mechanism

DOI Full Paper Access

67

Citations

25

References

2011

Year

Andrea Valentine, Martin O’Rourke, Anita Yakkundi, Jenny Worthington, Michelle B. Hookham, Roy Bicknell, Helen O. McCarthy, Keeva McClelland, Lynn McCallum, Hayder Dyer,

Clinical Cancer Research

Abstract

FKBPL and its peptide derivative AD-01 have potent antiangiogenic activity. Thus, these agents offer the potential of an attractive new approach to antiangiogenic therapy.

References

	Year	Citations

Page 1